Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature
- PMID: 22386940
- DOI: 10.1016/j.metabol.2012.01.005
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature
Abstract
X-linked nephrogenic diabetes insipidus (NDI) is a rare disease characterized by a malfunctioning renal response to the antidiuretic hormone arginine vasopressin (AVP) due to mutations in the AVPR2 gene. A limited number of mutations in the AVPR2 gene resulting in partial phenotype have been described so far. In this mini-review the retrospective analysis of 13 known AVPR2 mutations that have been previously shown in vitro to partially abolish AVPR2 function is described, along with a novel mutation diagnosed in a kindred with partial NDI. In the present study, a 14 year old male and his 73 year old maternal grandfather were diagnosed with partial NDI based on the clinical phenotype, the water deprivation test and the inadequate response to 1-desamino-8-d-arginine vasopressin (DDAVP) administration. Sequencing analysis of the AVPR2 gene revealed the novel missense mutation p.N317S (g.1417A > G) in both patients. This mutation was re-created by site directed mutagenesis in an AVPR2 cDNA expression vector and was functionally characterized, in terms of arginine vasopressin (AVP) and DDAVP response. AVPR2 activity of the p.N317S mutant receptor after the AVP and DDAVP administration, as assessed by cAMP production was reduced and impaired when compared to cells that expressed the wild type AVPR2 gene. In conclusion, the affected members of this family have X-linked NDI with partial resistance to AVP, due to a missense mutation in the AVPR2 gene.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.Clin Endocrinol (Oxf). 2008 Mar;68(3):395-403. doi: 10.1111/j.1365-2265.2007.03054.x. Epub 2007 Oct 17. Clin Endocrinol (Oxf). 2008. PMID: 17941907
-
AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.J Cell Physiol. 2008 Dec;217(3):605-17. doi: 10.1002/jcp.21552. J Cell Physiol. 2008. PMID: 18726898 Review.
-
Vasopressin receptor mutations causing nephrogenic diabetes insipidus.Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):387-94. Proc Assoc Am Physicians. 1998. PMID: 9756088 Review.
-
[Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1401-5. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12509923 Chinese.
-
Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.Horm Res Paediatr. 2010;73(5):349-54. doi: 10.1159/000308167. Epub 2010 Apr 14. Horm Res Paediatr. 2010. PMID: 20389105
Cited by
-
Three Pediatric Patients with Congenital Nephrogenic Diabetes Insipidus due to AVPR2 Nonsense Mutations and Different Clinical Manifestations: A Case Report.Case Rep Nephrol Dial. 2023 Oct 18;13(1):162-172. doi: 10.1159/000533895. eCollection 2023 Jan-Dec. Case Rep Nephrol Dial. 2023. PMID: 37900924 Free PMC article.
-
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.Eur J Pediatr. 2016 May;175(5):727-33. doi: 10.1007/s00431-015-2684-4. Epub 2016 Jan 21. Eur J Pediatr. 2016. PMID: 26795631 Free PMC article.
-
Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus.Sci Rep. 2021 May 26;11(1):11057. doi: 10.1038/s41598-021-90736-z. Sci Rep. 2021. PMID: 34040143 Free PMC article.
-
Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus.PLoS One. 2016 Sep 20;11(9):e0163086. doi: 10.1371/journal.pone.0163086. eCollection 2016. PLoS One. 2016. PMID: 27649563 Free PMC article.
-
Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.Clin Pediatr Endocrinol. 2022;31(2):87-92. doi: 10.1297/cpe.2021-0032. Epub 2022 Feb 18. Clin Pediatr Endocrinol. 2022. PMID: 35431445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous